Background illustration for clinical trials search

Migraine Clinical Trials

Browse 180 migraine clinical trials enrolling across the United States and Canada. 52 people applied to migraine studies last month. Search by city or state to find one near you.

Filter
1

Closed-loop rTMS-EEG During Visuomotor Integration.

for
Visuomotor Skills, Brain Lesion (General)
Location: Charleston SC
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT07249801

Recruiting

Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy

for
Alzheimer Dementia, Alzheimer Disease,
Location: Sevierville TN, Knoxville TN, Oak Ridge TN,
Sponsor: Covenant Health, US

Sex: All

Age: 60 - 70+

Code: NCT07222280

Recruiting

Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study

for
Multiple Sclerosis, Pathologic Processes,
Location: Austin TX
Sponsor: University of Texas at Austin

Sex: All

Age: 18 - 70+

Code: NCT07759115

Recruiting

Trans-Auricular Stimulation for Postoperative Inflammation in Spine Surgery

for
Spinal Fusion, Hyperglycemia, Postoperative Pain Management,
Location: St Louis MO
Sponsor: Alexander T. Yahanda

Sex: All

Age: 18+

Code: NCT07218133

Recruiting

Effects of Acute Ketone Supplementation on the Brain

for
Brain Health
Location: Columbus OH
Sponsor: Christopher Crabtree

Sex: All

Age: 45 - 65

Code: NCT07711990

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Apple Health Study

for
Mental Health, Sleep, Exercise, Hormones, Metabolic Health,
Location: Boston MA, Washington D.C. DC
Sponsor: Apple Inc.

Sex: All

Age: 18+

Code: NCT06958523

Recruiting

Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control

for
Movement Disorders (Incl Parkinsonism), Stroke,
Location: Pittsburgh PA
Sponsor: Jorge Gonzalez-Martinez

Sex: All

Age: 18 - 70+

Code: NCT07056361

Recruiting

Effect of Ultrasound-Guided Dry Needling Targeting Rectus Capitus Posterior Major on Individuals With Headaches

for
Headache Disorders, Primary, Headache, Cervicogenic
Location: Lubbock TX
Sponsor: Texas Tech University Health Sciences Center

Sex: All

Age: 18 - 65

Code: NCT07309874

Recruiting

Healing Tiny Minds: Rural Recovery Through Virtual and Lived Experience Care

for
Hypoxic Ischaemic Encephalopathy (HIE), Premature Birth,
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: All

Age: 0 - 5

Code: NCT06643598

Recruiting

Brain Development Research Program

for
Brain Disorders, Aicardi Syndrome
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 0+

Code: NCT00305305

Recruiting

A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes

for
Epilepsy in Children, Dyskinesias,
Location: Boston MA
Sponsor: Boston Children's Hospital

Sex: All

Age: 0 - 18

Code: NCT06585605

Recruiting

Can Targeted Education Impact the Current Standard of Care in Patients With Mild Traumatic Brain Injury?

for
Headache Disorders, Post-Concussion Syndrome,
Location: Toronto
Sponsor: Unity Health Toronto

Sex: All

Age: 18 - 65

Code: NCT03391583

Recruiting

Study of Selected X-Linked Disorders: Aicardi Syndrome

for
Aicardi Syndrome, Brain Disorders
Location: Houston TX
Sponsor: Baylor College of Medicine

Sex: All

Age: 0+

Code: NCT00697411

Recruiting

Pulsed vs Continuous Radiofrequency Neurotomy for Cervical Facet Joint Mediated Pain

for
Faceto-genic Neck Pain, Shoulder Pain Chronic,
Location: Toronto
Sponsor: Allevio Pain Management Clinic

Sex: All

Age: 18 - 70+

Code: NCT04124445

Recruiting

Lumbar Vein Embolization for Chronic Headaches With Nutcracker Physiology

for
Chronic Headache, Nutcracker Phenomenon, Renal,
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06077747

Recruiting

B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme

for
Brain and Nervous System
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT05474378

Phase 1, Recruiting

Neuropathic Pain and Operant Conditioning of Cutaneous Reflexes After SCI

for
Spinal Cord Injuries, Neuropathic Pain, Neurological Injury,
Location: Charleston SC
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT05492188

Recruiting

Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances

for
Autism Spectrum Disorder, Sleep Disorder, Neurological Disorder,
Location: Staten Island NY, Boulder CO, Santa Monica CA,
Sponsor: Vanda Pharmaceuticals

Sex: All

Age: 2 - 65

Code: NCT05361707

Phase 3, Recruiting

Home-based Neuromodulation to Target Depression And Memory Symptoms in Older Adults

for
Major Depressive Disorder, Alzheimer Disease, Dementia,
Location: Boston MA
Sponsor: Hebrew SeniorLife

Sex: All

Age: 55+

Code: NCT05976659

Recruiting

Human Epilepsy Genetics--Neuronal Migration Disorders Study

for
Brain Malformation, Neuronal Migration Disorder,
Location: Boston MA
Sponsor: Harvard University Faculty of Medicine

Sex: All

Age: 0+

Code: NCT00041600

Recruiting

What is migraine?

Migraine is a brain condition, not a blood vessel problem or a stress reaction. An attack usually brings throbbing pain on one side of the head, along with nausea and sensitivity to light and sound, and it can last from a few hours to three days. About 1 in 4 people with migraine get an aura first, visual disturbances like flashing lights or zigzag lines that come before the pain. Doctors sort migraine by frequency: episodic means fewer than 15 headache days a month, chronic means 15 or more, with at least 8 of them migraine days, for more than three months.

For most of medical history, migraine was treated with medicines borrowed from other conditions: blood pressure pills, antidepressants, epilepsy drugs. That changed in 2018, when the first medicine designed specifically for migraine was approved. It blocks a molecule called CGRP, which the brain releases during an attack. There are now four CGRP antibodies given by injection and several CGRP blocking pills, called gepants, and they treat both attacks and prevention. In a 2025 real world study of more than 2,000 patients, about 47 percent of people on a CGRP antibody had a meaningful response at three months, compared with about 35 percent on traditional preventives.

Types of migraine clinical trials

Who can participate in migraine clinical trials?

Episodic and chronic migraine, and why the line matters for trials

Do migraine trial participants get paid?

What is the difference between a migraine and a headache?

How to Enroll in a Clinical Trial for Migraine